Celgene Corporation announced the election of Michael W. Bonney to its Board of Directors. Mr. Bonney served as Chief Executive Officer and a member of the Board of Directors of Cubist Pharmaceuticals Inc. from June 2003 until his retirement on December 31, 2014. Mr. Bonney currently serves as a director of Alnylam Pharmaceuticals Inc. He is also a trustee of the Tekla complex of life sciences and healthcare dedicated funds.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
108.2 USD | +0.10% | -1.97% | +68.89% |
- Stock Market
- Equities
- CELG Stock
- News Celgene
- Celgene Corporation Elects Michael W. Bonney to its Board of Directors